Form 4 for APH Amphenol
Accepted 2025-04-29 00:00:00 ET · period of report 2025-04-25 · accession 0001104659-25-041334 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-04-29 | 2025-04-25 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | M - OptEx | $22.37 | +30.0K | 30.0K | New | +$671.1K |
| D | 2025-04-29 | 2025-04-25 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | S - Sale+OE | $76.28 | -175.0K | 51.4K | -77% | -$13.35M |
| D | 2025-04-29 | 2025-04-25 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | M - OptEx | $22.37 | +175.0K | 226.4K | +340% | +$3.91M |
| DI | 2025-04-29 | 2025-04-25 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | S - Sale+OE | $76.22 | -30.0K | 0 | -100% | -$2.29M |
| D | 2025-04-29 | 2025-04-25 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | M - OptEx | $0.00 | -175.0K | 125.0K | -58% | $0 |
| DI | 2025-04-29 | 2025-04-25 | APH | D'AMICO LANCE E | SVP, Sec, GenCounsel | M - OptEx | $0.00 | -30.0K | 70.0K | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-04-25 | M | A | 30,000 | $22.37 | 30,000 | I | — | — | |
| 2 | Common | Class A Common Stock | 2025-04-25 | S | D | 175,000 | $76.28 | 51,400 | D By Lance E. D'Amico 2024 Irrevocable Trust | — | — | (F2) This transaction was executed in multiple trades ranging from $76.0101 to $76.4810. (F1) The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Class A Common Stock | 2025-04-25 | M | A | 175,000 | $22.37 | 226,400 | D By Lance E. D'Amico 2024 Irrevocable Trust | — | — | |
| 4 | Common | Class A Common Stock | 2025-04-25 | S | D | 30,000 | $76.22 | 0 | I | — | — | (F1) The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F3) This transaction was executed in multiple trades ranging from $75.9300 to $76.3975. |
| 5 | Derivative | Stock Option | 2025-04-25 | M | D | 175,000 | $0.00 | 125,000 | D By Lance E. D'Amico 2024 Irrevocable Trust | $22.37 · 2020-05-23 to 2029-05-23 | 175,000 Class A Common Stock | (F4) These options were transferred to the Lance E. D'Amico 2024 Irrevocable Trust for no consideration. |
| 6 | Derivative | Stock Option | 2025-04-25 | M | D | 30,000 | $0.00 | 70,000 | I | $22.37 · 2020-05-23 to 2029-05-23 | 30,000 Class A Common Stock |